Expanded Access of Axatilimab to Treat a Single Patient With Chronic Graft Versus Host Disease (GVHD)

Incyte

Status

Conditions: Chronic Graft Vs. Host Disease

Treatments: Drug: axatilimab

Study type: Expanded Access

Funder types: Industry

Identifiers

NCT05544032

I-34176-25-07

Details and patient eligibility

About

This program is being offered on a patient by patient basis and will require company, Institutional Review Board/Independent Ethics Committee and Single Patient IND approval.

Sex

Ages: 6+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

-

Exclusion criteria

-